Folate Analog Metabolic Inhibitor class drugs

9 results

  • folotyn

    (pralatrexate)
    Acrotech Biopharma Inc
    FOLOTYN is indicated for treating patients with relapsed or refractory peripheral T-cell lymphoma (PTCL). Its approval is based on overall response rates, with continued approval dependent on confirmation of clinical benefits in future trials.
    Medication Details
    Drug Interactions

  • jylamvo

    (Methotrexate)
    SHORLA ONCOLOGY INC.
    JYLAMVO is indicated for treating acute lymphoblastic leukemia in adults and pediatric patients, mycosis fungoides, relapsed non-Hodgkin lymphomas, rheumatoid arthritis in adults, polyarticular juvenile idiopathic arthritis in pediatrics, and severe psoriasis in adults.
    Medication Details
    Drug Interactions

  • methotrexate

    (Methotrexate)
    Chartwell RX, LLC
    Methotrexate tablets are indicated for treating neoplastic diseases (acute lymphoblastic leukemia, mycosis fungoides, relapsed non-Hodgkin lymphomas), rheumatoid arthritis in adults, polyarticular juvenile idiopathic arthritis in pediatric patients, and severe psoriasis in adults.
    Medication Details
    Drug Interactions

  • otrexup

    (methotrexate)
    Antares Pharma, Inc.
    Otrexup is indicated for managing severe, active rheumatoid arthritis in adults and children with polyarticular juvenile idiopathic arthritis, as well as for the symptomatic control of severe psoriasis in adults unresponsive to other treatments. It is not for neoplastic diseases.
    Medication Details
    Drug Interactions

  • otrexup

    (methotrexate)
    Otter Pharmaceuticals, LLC
    Otrexup is indicated for managing severe, active rheumatoid arthritis in adults and children with polyarticular juvenile idiopathic arthritis, unresponsive to first-line therapies. It is also approved for adults with severe, recalcitrant psoriasis unresponsive to other treatments. It is not intended for neoplastic disease treatment.
    Medication Details
    Drug Interactions

  • pemetrexed

    (Pemetrexed disodium)
    Sandoz Inc.
    Pemetrexed Injection is indicated for the initial treatment of metastatic non-squamous non-small cell lung cancer (NSCLC), in combination with chemotherapy or as a maintenance single agent, and for malignant pleural mesothelioma in combination with cisplatin for patients not eligible for surgery.
    Medication Details
    Drug Interactions

  • pemetrexed

    (Pemetrexed disodium)
    Ingenus Pharmaceuticals, LLC
    Pemetrexed for Injection is indicated for the initial treatment of metastatic non-squamous non-small cell lung cancer (NSCLC) in combination with pembrolizumab or cisplatin, and as a maintenance or single-agent therapy for recurrent NSCLC. It is also used with cisplatin for malignant pleural mesothelioma. Not for squamous NSCLC.
    Medication Details
    Drug Interactions

  • rasuvo

    (methotrexate)
    Medexus Pharma Inc.
    Rasuvo is indicated for managing severe, active rheumatoid arthritis in adults and polyarticular juvenile idiopathic arthritis in children who haven't responded to or are intolerant of first-line therapies. It also treats severe psoriasis in adults unresponsive to other therapies, ensuring proper diagnosis beforehand. Not for neoplastic diseases.
    Medication Details
    Drug Interactions

  • xatmep

    (Methotrexate)
    Azurity Pharmaceuticals, Inc.
    XATMEP is indicated for treating pediatric patients with acute lymphoblastic leukemia (ALL) as part of a chemotherapy regimen, and for managing active polyarticular juvenile idiopathic arthritis (pJIA) in patients unresponsive or intolerant to first-line NSAID therapy.
    Medication Details
    Drug Interactions